Cargando…

Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy

BACKGROUND: Platelets from untreated periodontitis patients are hyper-reactive and form more platelet-leukocyte complexes compared to cells from individuals without periodontitis. It is not known whether the improvement of the periodontal condition achievable by therapy has beneficial effects on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Arvanitidis, Efthymios, Bizzarro, Sergio, Alvarez Rodriguez, Elena, Loos, Bruno G., Nicu, Elena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292810/
https://www.ncbi.nlm.nih.gov/pubmed/28190975
http://dx.doi.org/10.1186/s12959-016-0125-x
_version_ 1782504995165306880
author Arvanitidis, Efthymios
Bizzarro, Sergio
Alvarez Rodriguez, Elena
Loos, Bruno G.
Nicu, Elena A.
author_facet Arvanitidis, Efthymios
Bizzarro, Sergio
Alvarez Rodriguez, Elena
Loos, Bruno G.
Nicu, Elena A.
author_sort Arvanitidis, Efthymios
collection PubMed
description BACKGROUND: Platelets from untreated periodontitis patients are hyper-reactive and form more platelet-leukocyte complexes compared to cells from individuals without periodontitis. It is not known whether the improvement of the periodontal condition achievable by therapy has beneficial effects on the platelet function. We aimed to assess the effects of periodontal therapy on platelet reactivity. METHODS: Patients with periodontitis (n = 25) but unaffected by any other medical condition or medication were included and donated blood before and after periodontal therapy. Reactivity to ADP or oral bacteria was assessed by flow cytometric analysis of membrane markers (binding of PAC-1, P-selectin, CD63) and platelet-leukocyte complex formation. Reactivity values were expressed as ratio between the stimulated and unstimulated sample. Plasma levels of soluble (s) P-selectin were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: Binding of PAC-1, the expression of P-selectin and CD63 in response to the oral bacterium P. gingivalis were lower at recall (1.4 ± 1.1, 1.5 ± 1.2, and 1.0 ± 0.1) than at baseline (2.7 ± 4.1, P = 0.026, 6.0 ± 12.5, P = 0.045, and 2.7 ± 6.7, P = 0.042, respectively). Formation of platelet-leukocyte complexes in response to P. gingivalis was also reduced at recall compared to baseline (1.2 ± 0.7 vs. 11.4 ± 50.5, P = 0.045). sP-selectin levels were significantly increased post-therapy. CONCLUSIONS: In periodontitis patients, the improvement of the periodontal condition is paralleled by a reduction in platelet hyper-reactivity. We suggest that periodontal therapy, as an intervention for improved oral health, can facilitate the management of thrombotic risk, and on the long term can contribute to the prevention of cardiovascular events in patients at risk. TRIAL REGISTRATION: Current Controlled Trials identifier ISRCTN36043780. Retrospectively registered 25 September 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12959-016-0125-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5292810
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52928102017-02-10 Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy Arvanitidis, Efthymios Bizzarro, Sergio Alvarez Rodriguez, Elena Loos, Bruno G. Nicu, Elena A. Thromb J Research BACKGROUND: Platelets from untreated periodontitis patients are hyper-reactive and form more platelet-leukocyte complexes compared to cells from individuals without periodontitis. It is not known whether the improvement of the periodontal condition achievable by therapy has beneficial effects on the platelet function. We aimed to assess the effects of periodontal therapy on platelet reactivity. METHODS: Patients with periodontitis (n = 25) but unaffected by any other medical condition or medication were included and donated blood before and after periodontal therapy. Reactivity to ADP or oral bacteria was assessed by flow cytometric analysis of membrane markers (binding of PAC-1, P-selectin, CD63) and platelet-leukocyte complex formation. Reactivity values were expressed as ratio between the stimulated and unstimulated sample. Plasma levels of soluble (s) P-selectin were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: Binding of PAC-1, the expression of P-selectin and CD63 in response to the oral bacterium P. gingivalis were lower at recall (1.4 ± 1.1, 1.5 ± 1.2, and 1.0 ± 0.1) than at baseline (2.7 ± 4.1, P = 0.026, 6.0 ± 12.5, P = 0.045, and 2.7 ± 6.7, P = 0.042, respectively). Formation of platelet-leukocyte complexes in response to P. gingivalis was also reduced at recall compared to baseline (1.2 ± 0.7 vs. 11.4 ± 50.5, P = 0.045). sP-selectin levels were significantly increased post-therapy. CONCLUSIONS: In periodontitis patients, the improvement of the periodontal condition is paralleled by a reduction in platelet hyper-reactivity. We suggest that periodontal therapy, as an intervention for improved oral health, can facilitate the management of thrombotic risk, and on the long term can contribute to the prevention of cardiovascular events in patients at risk. TRIAL REGISTRATION: Current Controlled Trials identifier ISRCTN36043780. Retrospectively registered 25 September 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12959-016-0125-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-06 /pmc/articles/PMC5292810/ /pubmed/28190975 http://dx.doi.org/10.1186/s12959-016-0125-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Arvanitidis, Efthymios
Bizzarro, Sergio
Alvarez Rodriguez, Elena
Loos, Bruno G.
Nicu, Elena A.
Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title_full Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title_fullStr Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title_full_unstemmed Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title_short Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
title_sort reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292810/
https://www.ncbi.nlm.nih.gov/pubmed/28190975
http://dx.doi.org/10.1186/s12959-016-0125-x
work_keys_str_mv AT arvanitidisefthymios reducedplatelethyperreactivityandplateletleukocyteaggregationafterperiodontaltherapy
AT bizzarrosergio reducedplatelethyperreactivityandplateletleukocyteaggregationafterperiodontaltherapy
AT alvarezrodriguezelena reducedplatelethyperreactivityandplateletleukocyteaggregationafterperiodontaltherapy
AT loosbrunog reducedplatelethyperreactivityandplateletleukocyteaggregationafterperiodontaltherapy
AT nicuelenaa reducedplatelethyperreactivityandplateletleukocyteaggregationafterperiodontaltherapy